This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
By: Michael Moustakakis, MD, Group Medical Director for DaVita Extreme heat waves trigger standard public health advice everywhere: Drink plenty of water. For the general public, it’s a vital strategy to stay healthy and avoid heatstroke. But for the approximately 550,000 Americans living with end stage kidney disease (ESKD) and managing life on dialysis, this […]
With more than 90,000 people in the U.S. on the national transplant waitlist, the demand for life-saving organs far outpaces the supply. Living donation offers a strong pathway to addressing this public health challenge, and supporting a larger potential donor pool requires providing clarity on perceived barriers in the process. Angela Laino, a DaVita social […]
New data from the MOTheR trial1, one of the most rigorous head-to-head studies of advanced dialysis therapies to date, marks an important step forward in how the kidney care community approaches treatment for patients with end stage kidney disease. Presented at the European Renal Association (ERA) Congress in June 2026, the prospective randomized controlled trial […]
The journey to receiving a kidney transplant can be a complex and deeply emotional experience. To navigate the intricate path that includes education, care coordination and personal support, patients often rely on their multidisciplinary care teams as they work to reach this life-changing milestone. DaVita teammates — from facility administrators and social workers to patient […]
While kidney transplant is the optimal treatment path for end stage kidney disease (ESKD), complex logistical, financial and educational barriers can often stand in the way for many patients interested in pursuing it. The process can require rigorous medical, financial and emotional preparation. Clinical social workers help with this. In addition to guiding patients to […]